For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251001:nRSA6476Ba&default-theme=true
RNS Number : 6476B Ilika plc 01 October 2025
1 October 2025
Ilika plc
("Ilika", the "Group". or the "Company")
Exercise of Options, Issue of New Ordinary Shares and Total Voting Rights
Ilika (AIM: IKA), a pioneer in solid-state battery technology, announces
that, following the vesting and exercise of options under the Company's share
option schemes, it has issued 30,000 new ordinary shares of 1p each in the
Company ("New Ordinary Shares"). Accordingly, the Company has applied to the
London Stock Exchange for the New Ordinary Shares to be admitted to trading on
AIM ("Admission"). It is expected that Admission will occur on or around 8.00
a.m. on 6 October 2025.
Total Voting Rights
Following Admission, the Company's issued share capital will comprise
180,832,175 Ordinary Shares and that number may be used by Shareholders in the
Company as the denominator for the calculations by which they will determine
if they are required to notify their interest in, or a change in their
interest in, the share capital of the Company under the FCA's Disclosure
Guidance and Transparency Rules. The Company does not hold any shares in
treasury.
For more information contact:
Ilika Plc www.ilika.com (http://www.ilika.com/)
Graeme Purdy, Chief Executive
Via FTI Consulting
Jason Stewart, Chief Financial Officer
Cavendish Capital Markets Limited (Nomad and Broker) +44 (0)131 220 9772
Peter Lynch
+44 (0)131 220 9771
Neil McDonald
FTI Consulting (Comms Advisors) ilika@fticonsulting.com (mailto:ilika@fticonsulting.com)
Ben Brewerton
Elizabeth Adams
Dwight Burden
About Ilika plc - https://www.ilika.com (https://www.ilika.com/)
Ilika is a global expert in the development of solid state battery technology
for electric vehicles, medical devices and consumer appliances. The Company's
pioneering next-generation technologies aim to provide scalable, affordable
alternatives to conventional batteries, to industries which need to
incorporate a smaller, lighter, and safer power source in their products.
The Company has two product lines. Its Stereax batteries are designed for
powering miniature medical implants, industrial wireless sensors and Internet
of Things (IoT) applications and the Goliath large format batteries designed
for EV cars and cordless appliances.
Through its licensing business model, Ilika supplies its IP portfolio to both
OEMs and manufacturing partners in exchange for a license fee and future
royalties
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END IOEFSFFSFEISELS